EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Calcineurin with FK506 Reduces Tau Levels and Attenuates Synaptic Impairment Driven by Tau Oligomers in the Hippocampus of Male Mouse Models

Michela Marcatti, Batbayar Tumurbaatar, Michela Borghi, Jutatip Guptarak, Wen-Ru Zhang, Balaji Krishnan iD, Rakez Kayed, Anna Fracassi, Giulio Taglialatela iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25169092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Michela Marcatti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Mitchell Center for Neurodegenerative Disease, Department of Neurology, The University of Texas Medical Branch at Galveston, Galveston, TX 77550, USA. Hauptthemen laut MEDLINE: tau Proteins, Tacrolimus, Hippocampus, Calcineurin. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is the most common age-associated neurodegenerative disorder, characterized by progressive cognitive decline, memory impairment, and structural brain changes, primarily involving Aβ plaques and neurofibrillary tangles of hyperphosphorylated tau protein. Recent research highlights the significance of smaller Aβ and Tau oligomeric aggregates (AβO and TauO, respectively) in synaptic dysfunction and disease progression. Calcineurin (CaN), a key calcium/calmodulin-dependent player in regulating synaptic function in the central nervous system (CNS) is implicated in mediating detrimental effects of AβO on synapses and memory function in AD. This study aims to investigate the specific impact of CaN on both exogenous and endogenous TauO through the acute and chronic inhibition of CaN. We previously demonstrated the protective effect against AD of the immunosuppressant CaN inhibitor, FK506, but its influence on TauO remains unclear. In this study, we explored the short-term effects of acute CaN inhibition on TauO phosphorylation and TauO-induced memory deficits and synaptic dysfunction. Mice received FK506 post-TauO intracerebroventricular injection and TauO levels and phosphorylation were assessed, examining their impact on CaN and GSK-3β. The study investigated FK506 preventive/reversal effects on TauO-induced clustering of CaN and GSK-3β. Memory and synaptic function in TauO-injected mice were evaluated with/without FK506. Chronic FK506 treatment in 3xTgAD mice explored its influence on CaN, Aβ, and Tau levels. This study underscores the significant influence of CaN inhibition on TauO and associated AD pathology, suggesting therapeutic potential in targeting CaN for addressing various aspects of AD onset and progression. These findings provide valuable insights for potential interventions in AD, emphasizing the need for further exploration of CaN-targeted strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsTacrolimusHippocampusCalcineurinDisease Models, AnimalSynapsesCalcineurin InhibitorsAnimalsMaleMicePhosphorylationAlzheimer DiseaseGlycogen Synthase Kinase 3 beta

Stichwörter der Autor:innen

Alzheimer’s diseaseFK506Taucalcineurinoligomers

Substanzen

tau ProteinsTacrolimusCalcineurinCalcineurin InhibitorsGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Mitchell Center for Neurodegenerative Disease, Department of Neurology, The University of Texas Medical Branch at Galveston, Galveston, TX 77550, USA.

ORCID-Profile: Balaji Krishnan, Giulio Taglialatela

Förderung

  • NIH HHS
  • NIA NIH HHS
  • Alzheimer's Association
  • NIH/NIA
  • Alzheimer’s Association Research Fellowship

Zitieren

APA

Marcatti, M., Tumurbaatar, B., Borghi, M., Guptarak, J., Zhang, W. R., Krishnan, B., Kayed, R., Fracassi, A., & Taglialatela, G. (2024). Inhibition of Calcineurin with FK506 Reduces Tau Levels and Attenuates Synaptic Impairment Driven by Tau Oligomers in the Hippocampus of Male Mouse Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25169092

Vancouver

Marcatti M, Tumurbaatar B, Borghi M, Guptarak J, Zhang WR, Krishnan B, et al. Inhibition of Calcineurin with FK506 Reduces Tau Levels and Attenuates Synaptic Impairment Driven by Tau Oligomers in the Hippocampus of Male Mouse Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25169092

BibTeX
@article{Marcatti2024,
  author = {Marcatti, Michela and Tumurbaatar, Batbayar and Borghi, Michela and Guptarak, Jutatip and Zhang, Wen-Ru and Krishnan, Balaji and Kayed, Rakez and Fracassi, Anna and Taglialatela, Giulio},
  title = {Inhibition of Calcineurin with FK506 Reduces Tau Levels and Attenuates Synaptic Impairment Driven by Tau Oligomers in the Hippocampus of Male Mouse Models},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25169092}
}
Kostenlos starten →